Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 70010-032

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 70010-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10-mg-container-label (10 mg)

This is a description for a medication with the NDC code 70010-030-01. The medication is in capsule form and contains Dextroamphetamine Saccharate, Dextroamphetamine, Amphetamine Sulfate USP, Amphetamine Aspartate Monohydrate, and Amphetamine Sulfate. The total amphetamine base equivalence is 6.3 mg. The medication should be stored between 20-25°C (68-77°F) with excursions allowed between 15-30°C (59-86°F). The medication should be dispensed in a tight, light-resistant container and kept out of reach of children. The medication guide should be provided separately to each patient. This medication is manufactured by Granules Pharmaceuticals Inc. and is prescription-only.*

FDA Label Image

15-mg-container-label (15 mg)

This is a medication with the NDC (National Drug Code) 70010-031-01. Each capsule contains a mixture of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate USP, Amphetamine Sulfate USP. The total equivalence of amphetamine base is 9.4mg. It is an extended-release capsule that should be stored in a tight, light-resistant container between 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) as defined by the USP. The medication guide should be consulted for complete information. This is a prescription-only medication that should be kept out of reach of children. The manufacturer is Granules Pharmaceuticals Inc.*

FDA Label Image

20-mg-container-label (20 mg)

This is a description of a medication with the NDC number 70010-032-01. The medication comes in a container of 100 capsules and is only available with a prescription. Each capsule includes 5.0 mg of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine, and amphetamine sulfate. The total amphetamine base equivalence per capsule is 12.5 mg. The medication is stored at a temperature of 20° to 25°C (68° to 77°F) but excursions are permitted between 15° to 30°C (59° to 86°F). The medication should be kept away from children, and the complete information is available in the package insert which can be printed at the website granulespharma.com. The medication is manufactured by Granules Pharmaceuticals Inc.*

FDA Label Image

25-mg-container-label (25 mg)

This is a medication guide for NDC 70010-033-01, a prescription drug that comes in the form of extended-release capsules containing Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate USP, and Amphetamine Sulfate USP. Each capsule contains 15.6 mg of total amphetamine base equivalence, and the medication should be stored at 20° to 25°C (68° to 77°F). The medication guide should be provided to each patient, and the medication should be kept out of the reach of children. The drug is manufactured by Granules Pharmaceuticals Inc. and requires a prescription.*

FDA Label Image

30-mg-container-label (30 mg)

This is a medication guide for extended-release capsules containing a mixture of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate, with a total amphetamine base equivalence of 18.8mg per capsule. Each capsule contains 7.5 mg of each ingredient. It is important to store the medication between 20°C to 25°C or 68°F to 77°F, with excursions between 15°C to 30°C or 59°F to 86°F. Dispense this medication in a tightly sealed container and keep it out of reach of children. This information is printed on a package insert and can be found on the manufacturer's website.*

FDA Label Image

5-mg-container-label (5 mg)

This is a description of medication information for NDC 70010-029-01 capsules containing a mixture of amphetamines with a total amphetamine base equivalence of 3.1 mg. It lists the individual components and their quantities, as well as instructions to store the medication between 20°C to 25°C and dispense it in a tight, light-resistant container. The manufacturer is Granules Pharmaceuticals Inc. The package insert should be consulted for complete information. The medication guide can be accessed online. The medication should be kept out of reach of children.*

FDA Label Image

Figure-1 (Figure 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.